Paris - Delayed Quote EUR
GeNeuro SA (GNRO.PA)
0.0736
+0.0046
+(6.67%)
As of 2:00:26 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
14,357.3000
14,357.3000
11,818.4000
6,832.9000
7,459.1000
Operating Income
-14,357.3000
-14,357.3000
-11,818.4000
-6,832.9000
-7,459.1000
Net Non Operating Interest Income Expense
-876.7000
-876.7000
-261.7000
-38.7000
-1,441.5000
Pretax Income
-14,752.8000
-14,752.8000
-12,197.7000
-6,817.7000
-8,962.3000
Tax Provision
4.2000
4.2000
2.1000
0
0
Net Income Common Stockholders
-14,757
-14,757
-12,199.8000
-6,817.7000
-8,962.3000
Diluted NI Available to Com Stockholders
-14,757
-14,757
-12,199.8000
-6,817.7000
-8,962.3000
Basic EPS
-0.54
-0.59
-0.51
-0.32
-0.45
Diluted EPS
-0.54
-0.59
-0.51
-0.32
-0.45
Basic Average Shares
24,858.3100
25,011.8640
23,898.3170
21,280.0090
19,969.2930
Diluted Average Shares
24,858.3100
25,011.8640
23,898.3170
21,727.5000
19,969.2930
Total Operating Income as Reported
-14,357.3000
-14,357.3000
-11,229.2000
-6,365.7000
-7,459.1000
Rent Expense Supplemental
36.1000
36.1000
39.3000
34.1000
37.4000
Total Expenses
14,357.3000
14,357.3000
11,818.4000
6,832.9000
7,459.1000
Net Income from Continuing & Discontinued Operation
-14,757
-14,757
-12,199.8000
-6,817.7000
-8,962.3000
Normalized Income
-15,495.3135
-15,495.3135
-12,199.8000
-6,817.7000
-8,962.3000
Interest Income
75.9000
75.9000
7.6000
1.9000
3.1000
Interest Expense
--
--
--
0
72.3000
Net Interest Income
-876.7000
-876.7000
-261.7000
-38.7000
-1,441.5000
EBIT
-14,357.3000
-14,357.3000
-11,818.4000
-6,832.9000
-8,890
EBITDA
-14,063.5000
-14,063.5000
-11,530
-6,532.8000
-8,528.2000
Reconciled Depreciation
293.8000
293.8000
288.4000
300.1000
361.8000
Net Income from Continuing Operation Net Minority Interest
-14,757
-14,757
-12,199.8000
-6,817.7000
-8,962.3000
Total Unusual Items Excluding Goodwill
806.9000
806.9000
0
--
--
Total Unusual Items
806.9000
806.9000
0
--
--
Normalized EBITDA
-14,870.4000
-14,870.4000
-11,530
-6,532.8000
-8,528.2000
Tax Rate for Calcs
0.0001
0.0001
0.0001
0
0
Tax Effect of Unusual Items
68.5865
68.5865
0
0
0
12/31/2020 - 4/15/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MEB.MU Medincell SA
15.15
-1.37%
ALTHX.PA Theranexus Société Anonyme
1.3286
+100.88%
PHXM.PA PHAXIAM Therapeutics S.A.
0.3530
-0.56%
ALNEV.PA Neovacs S.A.
0.0070
-11.54%
DBV.PA DBV Technologies S.A.
2.2100
+13.72%
BION.SW BB Biotech AG Ord
28.50
-1.04%
BYSI BeyondSpring Inc.
1.7201
-1.14%
ADCT ADC Therapeutics SA
1.3900
+5.30%
ACIU AC Immune SA
1.5401
-1.90%
ALEC Alector, Inc.
1.0950
-1.35%